Can patients get up sooner after vein procedures without more bleeding?

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age ≥18 years. 2. No clinically significant neurological or cognitive impairment, and no pre-existing condition causing substantial limitation of lower-extremity mobility before the procedure. 3. Undergoing at least one of the following peripheral venous interventional procedures via femoral venous access, with postprocedural hemostasis achieved by manual compression: Lower-extremity venography alone; Inferior vena cava filter placement; Iliac vein stent placement; Endovascular thrombus removal for lower-extremity deep vein thrombosis; Other peripheral venous interventions using a 5-12 F sheath, including balloon angioplasty alone, pelvic vein embolization, or renal vein stent placement. 4. Able to understand the purpose and procedures of the study, provide written informed consent, and comply with the study procedures and follow-up. Exclusion Criteria: 1. Concomitant ipsilateral femoral arterial access during the index procedure or inadvertent percutaneous puncture of the femoral artery. 2. Visible access-site hematoma, persistent bleeding or oozing, pseudoaneurysm, or arteriovenous fistula occurring during femoral venous puncture or after sheath removal before randomization. 3. Requirement for additional non-protocol anticoagulation after the procedure, or any foreseeable condition preventing adherence to the assigned immobilization and bed-rest schedule or completion of the scheduled assessments. 4. Planned repeat puncture in the femoral region during the observation period or requirement for continued placement of a large-bore vascular sheath. 5. Use of thrombolytic agents during the procedure or requirement for continued intravenous thrombolytic therapy after the procedure. 6. Severe obesity or other conditions that make effective manual compression of the femoral access site difficult. 7. Hemodynamic instability identified before randomization. 8. Severe cardiac, hepatic, or renal insufficiency. Severe hepatic insufficiency is defined as alanine aminotransferase (ALT) \>2 times the upper limit of normal or aspartate aminotransferase (AST) \>2 times the upper limit of normal. Severe renal insufficiency is defined as serum creatinine \>1.5 times the upper limit of normal or estimated glomerular filtration rate (eGFR) \<45 mL/min/1.73 m². 9. Clinically significant coagulation abnormality, including a platelet count \<100 × 10\^9/L. 10. General anesthesia used during the index procedure.